Ecnoglutide is distinguished by its selective activation of the cAMP signalling pathway, reducing β-arrestin recruitment.

Insulin therapy is central to type 1 diabetes and many cases of type 2. It lowers glucose effectively, yet it also introduces predictable risks. Understanding side effects helps patients plan […] ...

Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...

‘Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author Patients taking Wegovy have nearly five times the risk of sudden sight loss ...

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor ...

Ozempic is intended to help people with diabetes manage blood sugar. A dietitian breaks down exactly what Ozempic is, and if using it for weight loss is even safe.

The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift ...

An NHS doctor has issued a warning about the "most common" side effect experienced by patients using weight loss injections ...

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic ...

An NHS doctor has warned anyone considering weight loss injections about a common side effect that can be "absolutely ...

(Viktoriya Skorikova/Moment/Getty Images) GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent ...

A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.